Abstract Background Malnutrition is a significant challenge in stroke patients, affecting both rehabilitation and independence
Not for human or veterinary use, diagnostic, or therapeutic purposes
MT-II has additional modifications compared to MT-I, which broaden its receptor affinity and therapeutic spectrum
Jump to 16:00 for this segment
It remodels the epigenome and protects DNA: By binding to promoter regions and loosening chromatin structure, Epitalon may restore youthful gene expression patterns, enhance DNA repair, and reduce mutation load, positioning it as a precision gene-expression modulator rather than a blunt genetic tool
30 These patients experienced further decreases in HbA 1c levels of 0.2%point in the 22 weeks following the switch